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Objectives Our aim was to determine reproducibility of the flow-mediated dilation (FMD) response profile, and discrimina-
tory ability of the components.
Background Brachial FMD is widely used to study conduit artery endothelial function. Automated B-mode image edge detec-
tion (B-ED) provides a full response profile. Reproducibility and biological relevance of these additional compo-
nents have not been fully explored.
Methods Forty-two healthy adults underwent FMD using B-ED repeated at fixed time intervals up to 3 months. The FMD
profile was assessed for diameter changes, area under the curve, and time course. Measures were compared in
25 adults with hypercholesterolemia, 25 subjects with diabetes, and 50 matched control subjects.
Results The maximum change in FMD was the most reproducible (coefficient of variation 9.8%, 10.6%, 6.6%, and 9.2% at
4 to 6 h, 1 week, 1 month, and 3 months, respectively). Most of the variability occurred between subjects rather than
within. All FMD measures except time course were significantly reduced in hypercholesterolemia and diabetes. Power
curves were generated to indicate the appropriate number of subjects for parallel and crossover study designs.
Conclusions Maximum FMD percentage change from baseline is the most reproducible of the response curve measures and
best identifies those with risk factors. Flow-mediated dilation measured by B-ED is robust and practical to assess
the effect of interventions on endothelial function in clinical trials. (J Am Coll Cardiol 2008;51:1959–64)
© 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.044t
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Ptherosclerosis begins in early life. Strategies to study and
anage ‘lifetime’ risk from atherosclerosis require robust inter-
ediate phenotypes, on the causal pathway for disease. Endo-
helial function is linked to cardiovascular risk factors, provides
rognostic information, and can be studied noninvasively by
easurement of flow-mediated dilation (FMD) (1). This
eflects local nitric oxide (NO) bioavailability and enables both
xamination of mechanisms involved in the initiation and
rogression of pre-clinical vascular disease and the impact of
cute and long-term interventions (2).
While the principles of FMD have not changed, operator
echnique and analysis have been refined (3). We now report
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008, accepted February 5, 2008.he reproducibility of components of the FMD response
ver time periods up to 3 months, and their ability to
iscriminate between healthy subjects and those with dia-
etes or hypercholesterolemia. Power curves have been
enerated to assist design of both crossover and parallel
See page 1965
rials to evaluate the impact of interventions on endothelial
unction. We have also compared B-mode edge detection
B-ED) software (Medical Imaging Applications, Coralville,
owa) to A-mode wall tracking (A-WT) (Vadirec, Medical
ystems Arnhem, Oosterbeek, the Netherlands) an early semi-
utomatic method relying on M-mode vascular images (4,5).
ethods
tudy protocols. STUDY 1: REPRODUCIBILITYOF FMDCOM-
ONENTS BY B-ED. We studied 42 healthy adults (19 men,
ean age 43 years [range 20 to 75 years]) free from
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Characterization of FMD May 20, 2008:1959–64cardiovascular risk factors at 4-
to 6-h, 1-week, 1-month, and
3-month intervals.
STUDY2: FMDPROFILE INSUBJECTS
WITH TYPE 2 DIABETES MELLITUS
(T2DM) OR HYPERCHOLESTER-
OLEMIA. Twenty-five patients
(16 men, age 53 years [range 39
to 67 years]) with T2DM 2
years duration with fasting glu-
cose 6.9 mmol/l (124 mg/dl)
and/or on hypoglycemic treat-
ment (16 sulphonylureas, 9
metformin, 7 combination, and
7 diet) were matched with 25
healthy control subjects re-
cruited contemporaneously.
Twenty-five patients (18 men,
ge 50 years [range 19 to 67 years]) with total fasting
holesterol 6.0 mmol/l (232 mg/dl) (7 on statins) were
ompared with 25 healthy control subjects matched for age,
ender, and vessel diameter.
TUDY 3: REPRODUCIBILITY OF FMD BY A-WT. We studied
6 healthy adults free of cardiovascular risks (14 men, 33
ears [range 23 to 61 years]) on 2 occasions 1 month apart.
ssessment of endothelial function. All subjects gave
nformed written consent. Studies were approved by the
Abbreviations
and Acronyms
A-WT  A-mode wall
tracking
B-ED  B-mode edge
detection
CV  coefficient of
variation
FMD  flow-mediated
dilation
FMDmax  maximum flow-
mediated dilation
percentage change from
baseline
NO  nitric oxide
T2DM  type 2 diabetes
mellitus
Figure 1 Image Acquisition and Readout for FMD Using B-ED a
(A) B-mode ultrasound image of the brachial artery, with region-of-interest box for
edge detection (B-ED). (C) B-mode image with perpendicular M-line for A-mode wal
quency signal. (Middle trace) Anterior and posterior wall motion. (Lower trace) Diocal ethics committee and were carried out under standard-
zed conditions by trained operators:
Rest 10 min in a warm, quiet room (22°C to 26°C) after
4 h abstinence from food and caffeinated drinks.
Right arm extended laterally and brachial artery imaged
longitudinally 5 to 10 cm above antecubital fossa (image
stability achieved by anterior plane, scanning through the
biceps muscle with the probe in a stereotactic holder with
micrometer movement).
Pneumatic cuff (7  30 cm) (Scanmed, Moreton-in-
Marsh, Gloucestershire, United Kingdom) placed imme-
diately below the medial epicondyle. Inflation time 5 min
at 300 mm Hg. The arm, hand, and head position noted,
along with the distance between the pneumatic cuff and
the probe. A thermal print of the arterial image was taken
for matching at subsequent visits.
B-mode ultrasound images were updated on the R-wave
of the electrocardiogram, with Doppler flow and electro-
cardiogram displayed continuously.
-ED methodology. A standard protocol was used as
reviously described (3). The lumen diameter was measured
rom within the same region-of-interest box for each image
Fig. 1A). Diameters were plotted for FMD and area under
he curve measurement (Fig. 1B). Additionally, the incre-
ental area under the diameter versus time curve was
alculated, accounting for baseline diameter over intervals
ost-cuff release of 0 to 1 min, 0 to 3 min, and 0 to 5 min
WT
etection diameter measurement. (B) Flow-mediated dilation (FMD) using B-mode
ing (A-WT). (D) A-mode wall tracking output. (Upper trace) A-mode radio-fre-
on waveform generating end-diastolic diameter. AUC  area under the curve.nd A-
edge d
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May 20, 2008:1959–64 Characterization of FMD0  cuff deflation point). The times to reach maximum
ilation and to recover to half the absolute change in
iameter after cuff release were also assessed to examine the
esponse time course after reactive hyperemia. All analyses
ere conducted by an experienced investigator (A.E.D.)
linded to subject identity and visit order.
-WT methodology. A standard protocol was used as
reviously described (6). The cuff was placed 4 to 6 cm
elow the elbow crease to reduce image movement on cuff
nflation/deflation. A single M-line was placed perpendicular
o the vessel walls on the image to record the systolic to
iastolic excursion of the brachial artery (Fig. 1C) providing
he distension waveform and end-diastolic diameter (Fig. 1D).
tatistical analysis. All measures are expressed as mean 
tandard deviation unless otherwise stated.
Reproducibility for each time interval between pairs of
isits was expressed as the coefficient of variation (CV) of a
ingle measurement, defined as the standard deviation of the
ifference between paired values divided by the mean and
ivided by 2, as previously described (3). Paired t tests
ere used to compare patients and control subjects. To
ssess the number of subjects required for crossover and
arallel studies, for 80% statistical power and 5% signifi-
ance, and to assess the effect of varying the number of
eadings pre- and post-treatment, power curves were con-
tructed from the between- and within-subject variances as
reviously reported (7). Reproducibility of B-ED and
-WT over 1 month was compared using Bland-Altman
lots. SPSS (version 12, SPSS Inc., Chicago, Illinois) was
sed for analyses.
esults
tudy 1. Six of 144 scans were excluded (1 noncompliance
ith fasting protocol, 2 poor image quality, 2 subject
ovement, 1 equipment failure). Baseline vessel diameter,
aseline blood flow, reactive hyperemia, blood pressure, and
eart rate were similar for each interval. The maximum
hange in diameter expressed as a percentage and as an
bsolute value, maximum flow-mediated dilation percentage
hange from baseline (FMDmax), and absolute FMD
hange from baseline, respectively, were the most reproducible
omponents of the FMD profile at each interval (Table 1).
aximum FMD percentage change from baseline corre-
ated inversely with age (p  0.01), female subjects had
ignificantly smaller vessels than male subjects (p  0.01),
nd vessel size correlated with age (p 0.01). Between- and
ithin-subject variance was similar at all visit intervals
13.3, 11.9, 14.3, and 11.1 and 1.3, 1.3, 0.6, and 1.1 for
tudies done 4 to 6 h, 1 week, 1 month, and 3 months apart,
espectively). We constructed power curves from the data
ecorded 4 to 6 h and 3 months apart for both crossover and
arallel studies for protocols using 1, 2, or 4 FMD mea-
urements before and after an intervention (Fig. 2). Increas-
ng the number of assessments in the protocol had minimal
mpact in a parallel study design. By contrast, in a crossover design, increasing the number of FMD scans reduced the
umber of subjects slightly, but at the cost of a more
omplex protocol.
tudy 2. Disease groups and control groups had similar
iameters and flows at baseline. All components of the
MD response except peak time and recovery half time
ere lower in subjects with T2DM or hypercholesterolemia,
ut did not further differentiate patients from control
ubjects compared with FMDmax. Absolute FMD change
rom baseline and FMDmax showed the greatest differences
etween patients and control subjects for both disease
roups (Table 2).
tudy 3. Comparing A-WT with B-ED over a 1-month
nterval, reproducibility of baseline diameter was compara-
le (CV 2.6% vs. 3.5%). However, FMD at 60 s after cuff
eflation using A-WT was lower (4.3  3.6% vs. 7.5  3.8%
t Visit 1, and 4.6 3.1% vs. 7.2 4.0% at Visit 2, both p
.01) and more variable (CV 17.8% vs. 8.6%) than B-ED
Fig. 3).
iscussion
e report the opportunity, afforded by current ultrasound
ethodology, to evaluate endothelial function in a repro-
ucible manner and the potential application to detect
bnormality in disease states. Power curves have been
onstructed demonstrating that FMD measurement is prac-
ical in both crossover and parallel studies.
In 1992, we described the noninvasive method for FMD,
hich has been shown to be NO dependent and also to
eflect coronary endothelial function (1,8,9). The technique
as been widely adopted in clinical research, but, manual
easurements are time consuming and subjective. Newer
emiautomatic measurement software is faster, less subjec-
ive, and potentially more reproducible. This, combined
ith greater image stability afforded by fixing the ultrasound
robe in an adjustable stereotactic clamp and adherence to a
igorous protocol, improves the accuracy and reproducibil-
ty. In contrast to early analyses, B-ED measures the whole
ilation profile. We show that, of all the potential measures,
MDmax is both the most reproducible and the best
iscriminator of endothelial function abnormalities between
ealth and disease. The ‘area under the response curve’ adds
ittle value compared with the simpler FMDmax. The time
o FMDmax and the recovery time were similar in health
nd disease suggesting that the magnitude rather than time
ourse of vasodilation best reflects differences in endothelial
unction.
A-mode wall tracking is more variable than B-ED,
espite excellent spatial resolution. This may reflect
ifficulty in maintaining positional stability of a single
-line without 2-dimensional image guidance. Measure-
ents must be performed at set time points (60 s),
imiting reproducibility and also producing lower FMD,
issing the maximal response in most cases. Maximalilation occurred between 24 s and 117 s (mean 59 s)
Reproducibility of FMD Responses
Table 1 Reproducibility of FMD Responses
4 to 6 h
(n  32)
Mean
Diff
SD
Diff
CV
(%)
1 Week
(n  34)
Mean
Diff
SD
Diff
CV
(%)
1 Month
(n  37)
Mean
Diff
SD
Diff
CV
(%)
3 Months
(n  35)
Mean
Diff
SD
Diff
CV
(%)
FMDmax (%) 8.1 3.7 7.5 3.4 8.1 3.7 7.8 3.1
8.1 3.8 0.29 1.12 9.8 7.5 3.4 0.07 1.12 10.6 8.1 4.0 0.03 0.75 6.6 8.2 3.7 0.38 1.04 9.2
FMD60s (%) 7.3 3.7 6.7 3.5 7.5 3.8 7.1 3.0
7.4 3.9 0.25 1.53 14.7 6.6 2.9 0.09 1.34 14.2 7.2 4.0 0.33 0.89 8.6 7.5 3.7 0.13 1.23 11.9
FMDabs (mm) 0.3 0.1 0.3 0.1 0.3 0.1 0.3 0.1
0.3 0.1 0.008 0.05 8.1 0.3 0.1 0.004 0.05 10.3 0.3 0.1 0.007 0.04 6.6 0.3 0.1 0.01 0.03 6.2
Time to FMDmax (s) 60.4 20 59.4 20 58.9 14 58.6 17
58.1 15 4.02 15.7 18.7 59.8 19 0.45 18.2 21.6 63.9 18 3.27 14.8 17.1 59.8 21 1.14 11.22 13.4
1⁄2 rec. time (min) 1.39 0.6 1.1 0.6 1.4 0.9 1.2 0.7
1.4 0.7 0.03 0.29 14.7 1.2 0.8 0.15 0.52 32.2 1.2 0.7 0.16 0.41 22.0 1.2 0.6 0.001 0.47 28.0
AUC 0 to 1 min 7.5 5 5.5 4 6.8 5 6.5 5
6.9 5 0.54 2.52 24.8 6.1 5 0.5 3.82 46.6 5.3 5 1.95 3.46 40.5 8.1 4 1.6 3.75 36.3
AUC 1 to 3 min 18.6 10 15.4 11 19.2 10 17.9 11
18.2 11 0.41 3.96 15.2 15.8 11 0.13 3.82 17.4 19.2 11 1.69 5.86 21.6 17.6 12 0.34 6.19 24.6
AUC 0 to 3 min 26.1 1 20.8 11 26.0 12 24.4 11
25.1 13 0.95 5.67 15.7 21.9 14 0.37 5.82 19.2 24.5 13 3.64 7.84 22.0 25.7 12 1.26 8.04 22.7
AUC 0 to 5 min 32.0 15 24.2 16 33.2 17 31.3 18
31.2 18 0.88 9.25 20.7 26.8 20 1.8 8.68 24.1 31.4 20 4.59 11.4 25.0 30.9 17 0.43 12.18 27.7
Baseline 3.7 0.8 3.7 0.8 3.8 0.8 3.8 0.8
Diameter (mm) 3.7 0.8 0.04 0.11 2.0 3.7 0.8 0.001 0.13 2.6 3.7 0.8 0.05 0.19 3.5 3.8 0.8 0.01 0.2 3.8
Characteristics of the flow-mediated dilation (FMD) response profile repeated at intervals of 4 h, 1 week, 1 month, and 3 months in Study 1 (healthy subjects). Data provided as mean  SD for Visits 1 and 2.
AUC  area under the curve; CV  coefficient of variation of paired differences; FMD  flow-mediated dilation; FMDabs  maximum absolute change in flow-mediated dilation; FMDmax  maximum percent change in flow-mediated dilation; FMD60s  percent change
in flow-mediated dilation at 60 s after cuff deflation; Mean diff  mean of paired differences; SD diff  standard deviation of paired differences; Time to FMDmax  time to reach maximal flow-mediated dilation after cuff release; 1⁄2 rec. time  time to return to one-half
absolute vessel size change after cuff deflation.
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May 20, 2008:1959–64 Characterization of FMDfter cuff release so that readings taken at 60 s are
aximal for only 30% of subjects (10).
The low CV with B-ED was accomplished by meticulous
tandardization of the technique and operator training.
hysiological variability can be reduced by controlling fac-
ors known to influence endothelial function, such as
emperature, recent food and drink intake, exercise, and
nfection (2,11). Previous studies have reported variability
uring the menstrual cycle (12). Although our study was not
esigned to test this issue, reproducibility was similar in
omen and men.
Figure 2 Number of Subjects Required in Crossover and Paralle
Relation between effect on maximum percent change in flow-mediated dilation (FM
study designs at 80% power and 5% significance, 4 to 6 h and 3 months apart wit
MD Response in Subjects With Diabetes or Hypercholesterolemia
Table 2 FMD Response in Subjects With Diabetes or Hypercho
T2DM
(n  25)
Control
Subjects
(n  25)
FMDmax (%) 4.0 2.4 6.5 2.4
FMDabs (mm) 0.16 0.09 0.26 0.09
FMD60s (%) 3.2 2.5 5.5 2.4
AUC 0 to 1 min 2.6 4.3 7.0 4.1
AUC 0 to 3 min 13.7 13.6 24.5 13.0
AUC 1 to 3 min 11.0 10.5 17.5 11.8
1⁄2 rec. time (s) 80.0 48.0 74.5 33.5
Time to FMDmax (s) 65.4 18.0 65.2 22.6
Baseline diameter (mm) 4.3 0.7 4.21 0.6
Baseline flow (ml/min) 32 17 25 12
Reactive hyperemia (%) 457 198 518 275ata provided as mean  SD and shown in descending order of significance of difference between type
Abbreviations as in Table 1.We investigated subjects age 20 to 71 years, with a wide
ange of vessel diameters and FMD responses, using a
rotocol that reflects predominantly NO bioavailability (9).
ilation induced by stimuli such as hand warming, pro-
onged ischemia, or cuff inflation above the site of measure-
ent are less NO dependent, less extensively studied, and
equire further evaluation of their biological significance
9,13).
A-mode wall tracking provided consistently lower FMD
han B-ED, likely due to a more distal cuff position used to
inimize movement artifact. Standardization of cuff posi-
igns for Given FMD Effect
and number of subjects required in crossover and parallel
onitoring strategies: 1, 2, or 4 measures pre- and post-treatment.
pared With That in Control Subjects
rolemia Compared With That in Control Subjects
e
Hypercholesterolemia
(n  25)
Control
Subjects
(n  25) p Value
01 4.3 2.3 7.2 2.3 0.0001
04 0.17 0.08 0.29 0.08 0.000008
07 3.7 2.3 6.4 2.4 0.0004
1 2.7 3.0 7.0 3.4 0.0001
9 12.3 10.0 26.6 13.0 0.00007
9.7 8.7 19.6 11.4 0.0005
60.1 28.5 79.9 49.2 0.09
55.0 13.2 58.3 17.4 0.5
4.0 0.7 4.1 0.6 0.09
23 21 18 12 0.6
617 231 642 350 0.6l Des
D) (%)
h 3 mCom
leste
p
Valu
0.00
0.00
0.00
0.00
0.00
0.05
0.7
0.9
0.2
0.1
0.62 diabetes mellitus (T2DM) cases and matched control subjects.
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Characterization of FMD May 20, 2008:1959–64ion is crucial in multicenter and interventional studies and may
xplain, in part, previously reported variation in FMD (14).
Flow-mediated dilation measured by B-ED is reproduc-
ble and practical for studying endothelial function in
linical research from a young age. As the major component
f variability in FMD is between subjects, crossover studies
an be performed with sufficient statistical power using
ubstantially fewer subjects than for parallel trial designs.
he additional complexity resulting from multiple assess-
ents of FMD adds very little to the power of the study.
his information on vascular disease biology complements
tudies of arterial structure and clinical outcome, which
equire larger and more expensive protocols.
eprint requests and correspondence: Ms. Ann E. Donald,
ascular Physiology Unit, Institute of Child Health, 30 Guilford
treet, London WC1N 1EH, United Kingdom. E-mail:
.Donald@ich.ucl.ac.uk.
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